Skip to main content

Table 3 Multivariate analysis of prognostic factors in 341 node negative patients aged less than 40 years

From: Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials

  Overall survival Distant disease-free survival
  HR 95% CI P HR 95% CI P
pT2 + pT3 1.75 0.99 to 3.10 0.06 1.33 0.83 to 2.15 0.24
Molecular subtype    0.02    0.08
   Basal 1    1   
   Luminal A 0.22 0.08 to 0.60   0.46 0.25 to 0.85  
   HER2 0.25 0.03 to 1.85   0.53 0.16 to 1.73  
   Luminal B 0.87 0.48 to 1.59   0.82 0.49 to 1.38  
Adjuvant chemotherapy 0.96 0.38 to 2.45 0.94